<

×

>

hide

You are viewing a Web site, archived on 23:42:35 Jan 11, 2017. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.

U.S. Senate Special Committee on Aging

“Sudden Price Spikes in Decades-Old Rx Drugs: Inside the Monopoly Business Model”

Date: Thursday, March 17, 2016 Time: 09:45 AM Location: Dirksen 562

Open in New Window

Member Statements

Senator Susan M. Collins R (ME)
- Adobe Acrobat Document Download Statement
Senator Claire McCaskill D (MO)
- Adobe Acrobat Document Download Statement

Witnesses

Panel I

Howard Dorfman
former Senior Vice Present and General Counsel

Turing Pharmaceuticals
- Adobe Acrobat DocumentDownload Testimony
Adaora Adimora M.D
Professor of Medicine, School of Medicine; Professor of Epidemiology, Gillings School of Public Health

University of North Carolina Chapel Hill
- Adobe Acrobat DocumentDownload Testimony
Shannon and Joshua Weston
parents of infant born with Toxoplasmosis
- Adobe Acrobat DocumentDownload Testimony

Panel II

Ronald Tilles
Interim CEO, and Chairman of the Board

Turing Pharmaceuticals
- Adobe Acrobat DocumentDownload Testimony
Michael Smith
Co-Founder and Senior Director of Business Development

Turing Pharmaceuticals
- Adobe Acrobat DocumentDownload Testimony
Dan Wichman
Partner and Analyst

Broadfin Capital
- Adobe Acrobat DocumentDownload Testimony